A new species of mosquito has been discovered in Kenya. What does this mean for the fight against malaria?

Published Date: 08 Mar 2023

The Kenya Institute of Medicine recently discovered a species of mosquito in Laisamis and Saku sub-counties of Marsabit County in northern Kenya.

Read Full News

Latest News

Ebola Bundibugyo Vaccine Candidates Could Enter Phase 1 Trials as Early as July

(Refiles to fix typo in ⁠country name)

G7 Leaders Call for Strong, Coordinated Response to Ebola Outbreak

G7 leaders called ⁠on Tuesday for a strong and ⁠coordinated response to the Ebola ⁠outbreak in ‌Congo, urging other nations to dedicate resources in a bid to ensure ‌the...

Advocacy Groups Urge U.S. to Share Experimental Ebola Drug for Outbreak Trials

A clutch of advocacy groups on Tuesday urged the U.S. government to make an experimental Ebola treatment by ⁠Mapp Biopharmaceutical available for clinical trials and...

Trust Calls for More Than Expertise Alone (part 2)

What does it take to earn patients’ trust? Historian Sophia Rosenfeld, PhD, of the University of Pennsylvania describes the elements that matter in addition to knowledge.

Beta-Lactam Alone Matches Combination Therapy in CAP

Adding azithromycin to beta-lactams in hospitalized patients with community-acquired pneumonia does not improve clinical efficacy, including those with SOFA scores ≥ 2.

US to Provide $50 Million More in Funding to Counter Ebola Outbreak

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Latest News

(Refiles to fix typo in ⁠country name)

G7 leaders called ⁠on Tuesday for a strong and ⁠coordinated response to the Ebola ⁠outbreak in ‌Congo, urging other nations to dedicate resources in a bid to ensure ‌the...

A clutch of advocacy groups on Tuesday urged the U.S. government to make an experimental Ebola treatment by ⁠Mapp Biopharmaceutical available for clinical trials and...

What does it take to earn patients’ trust? Historian Sophia Rosenfeld, PhD, of the University of Pennsylvania describes the elements that matter in addition to knowledge.

Adding azithromycin to beta-lactams in hospitalized patients with community-acquired pneumonia does not improve clinical efficacy, including those with SOFA scores ≥ 2.

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

News All Time

US Confirms New Screwworm Cases, as Ranchers Brace for Spread

The U.S. confirmed three additional cases of New World screwworm on Monday, raising the total number of cases to five since the first domestic screwworm infestation in six...

Congo Says Ebola Deaths Top 100 as Armed Groups Threaten Response

Democratic Republic of Congo on Monday said confirmed Ebola deaths had climbed to 101 and that the presence ⁠of armed groups was continuing to hinder the response in the...

Maternal RSV Vaccine Cuts Infant Hospitalization Risk by 68%

Maternal RSV vaccination during pregnancy is associated with protection against RSV-associated acute respiratory illness.

USDA Expects to Contain Screwworm Case in Texas, Rollins Says

U.S. Agriculture Secretary Brooke ⁠Rollins said on Thursday that the USDA believes ⁠it can contain a case of ⁠New World screwworm ‌in Texas, the first case in the state...

PAHO Strengthens Ebola Preparedness

The Pan American Health Organization said on Thursday it is stepping up efforts to help ⁠countries across the Americas to strengthen their preparedness for Ebola.

Romania Remains Europe’s Measles Hotspot

Romania’s children under 5 are experiencing the worst of Europe’s measles outbreaks. Are new policies sufficient to encourage more childhood vaccinations?

WHO Launches $518 Million Plan to Curb Africa Ebola Outbreak

The World Health Organization chief announced a $518 million six-month joint plan to fight Ebola on Friday, calling ⁠for money and political commitment to halt the spread of...

WHO Says Ebola Response Catching Up as Confirmed DRC Cases Hit 344

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Recommended News For You

The Kansas Cancer Center awarded two Indian American doctors professorships.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

Have the Harms of Lung Cancer Screening Been Exaggerated?

Recommended Articles For You

Understanding Iron Saturation Levels in Your Blood  

Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care 

The Growing Crisis of Aplastic Anemia: A Call for Action 

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Urinary tract cancer prediction models with high sensitivity and specificity

2.

Two medications might work better for breast cancers that are resistant to one.

3.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

4.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

5.

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

1.

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy 

2.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

3.

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer

4.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

5.

Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot